Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque Psoriasis

Clinical trial NCT01690299 · COMPLETED

Trial details

NCT number: NCT01690299
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Psoriasis Psoriatic Arthritis

Start date: 2012-10-01
Primary completion: 2014-07-03
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.